▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2612 by analyst upside · 2026-08-13
TDOC
Teladoc Health, Inc.
Healthcare · Market Cap $1B · P/E 0x
ANALYST PRICE TARGET
+16.1%
implied upside to consensus target
Current Price $6.71
Consensus Target $7.79
Bull Target $10.5
Bear Target $5.5
Analysts Covering 19
ANALYST CONSENSUS - HOLD
Strong Buy
1
Buy
4
Hold
14
Sell
0
52-Week Low $4.4
52-Week High $9.89
YTD Return -4.8%
FUNDAMENTALS
Market Cap $1B
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-0.98
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $2.5B
Profit Margin -7.1%
52-WEEK RANGE
52-Week Low $4.4
52-Week High $9.89
Current Price $6.71
Bear Target $5.5
Bull Target $10.5
● Now $6.71 ● Target $7.79
TRADING DATA
Avg Volume 4.9M
YTD Return -4.8%
Analyst Count 19
Consensus Hold
Upside to Target +16.1%
Last Updated 2026-08-13

ANALYST SUMMARY

Teladoc Health, Inc. (TDOC) is currently trading at $6.71 with a Wall Street consensus price target of $7.79, implying potential upside of 16.1% over the next 12 months. 19 analysts currently cover TDOC, with a consensus rating of Hold - 26% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $10.5, while the most cautious has a target of $5.5.

TDOC operates in the Healthcare sector with a market capitalisation of $1B. The stock is down 4.8% year-to-date and is currently trading near the lower end of its 52-week range of $4.4 – $9.89.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

AMN +7.9%
AMN Healthcare Services, Inc.
$1B · P/E 12.3x · Buy
HCSG +28.8%
Healthcare Services Group, Inc.
$1B · P/E 12.2x · Hold
BVS +20.7%
Bioventus Inc.
$1B · P/E 17.8x · Buy
PAHC +33.1%
Phibro Animal Health Corporation
$1B · P/E 14.6x · Hold
ABUS +20.7%
Arbutus Biopharma Corporation
$907M · P/E 5.5x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for TDOC, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Citigroup - Reiterated
Neutral → Neutral 2026-05-05 Building track record
Evercore ISI Group - Reiterated
In-Line → In-Line 2026-04-08 Building track record
Barclays - Reiterated
Equal-Weight → Equal-Weight 2026-03-26 Building track record
JP Morgan - Reiterated
Neutral → Neutral 2026-03-13 43% win rate (7 calls)
Deutsche Bank ↑ Upgrade
Hold → Buy 2026-03-10 Building track record
Citigroup - Reiterated
Neutral → Neutral 2026-03-03 Building track record
Oppenheimer - Reiterated
Outperform → Outperform 2026-03-03 14% win rate (7 calls)
Canaccord Genuity - Reiterated
Buy → Buy 2026-02-26 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
40
out of 100
Coverage depth
23/30
Consensus clarity
15/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →